Sabra Healthcare REIT Inc (SBRA)
Official siteREAL ESTATE • REIT - HEALTHCARE FACILITIES • NASDAQ
Market Cap: $5.33B
Last updated: Nov 17, 2026 at 4:32 PM ET
Sabra Healthcare REIT Inc (SBRA) Statistics
Sabra Healthcare REIT (SBRA) has a market cap of $5.33B and a P/FFO of 12.1x on its 2026 FFO estimate. Its share count is up 6.55% from a year earlier. Its dividend yield is 5.93%.
Total Valuation
Enterprise value is 45.02% above the market cap, as debt exceeds cash.
| Market Cap | $5.33B |
|---|---|
| Enterprise Value | $7.73B |
| Latest price (Nov 17, 2026) | $20.25 |
Key Dates
The next earnings report is expected on Feb 10, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Nov 13, 2026.
| Next Earnings Date | Feb 10, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 2, 2026 |
| Last Ex-Dividend Date | Nov 13, 2026 |
| Next Payment Date | Nov 30, 2026 |
| Fiscal Year End | December |
Valuation Ratios
P/FFO is 12.1x on the 2026 FFO estimate of $1.67 a share. Its year-end P/S ranged from 4.7x to 6.7x from 2016 to 2025.
| P/FFO (2026 estimate) | 12.1x |
|---|---|
| Forward P/E | 40.2x |
| P/S Ratio | 5.7x |
| Forward P/S | 6.2x |
| P/B Ratio | 1.8x |
| P/TBV Ratio | 1.9x |
| P/FCF Ratio | 15.1x |
| P/OCF Ratio | 13.3x |
Enterprise Valuation
Counting debt and cash, the company is valued at 27.1x EBITDA and 22.1x free cash flow.
| EV / Earnings | 108.5x |
|---|---|
| EV / Sales | 8.5x |
| EV / EBITDA | 27.1x |
| EV / FCF | 22.1x |
Price Statistics
The stock is up 13.60% over 52 weeks and trades 3.32% above its 50-day average.
| Beta (1Y) | -0.12 |
|---|---|
| 52-Week Change | +13.60% |
| 1-Month Change | +7.69% |
| 3-Month Change | +0.04% |
| 6-Month Change | -2.19% |
| 5-Year Change | +39.51% |
| 10-Year Change | -15.28% |
| Total Return (1Y) | +20.33% |
| Total Return (3Y CAGR) | +18.98% |
| Total Return (5Y CAGR) | +15.16% |
| Return vs SPY (1Y) | -0.72% |
| Max Drawdown (1Y) | -16.10% |
| Max Drawdown (3Y) | -16.80% |
| Sharpe Ratio (1Y) | 0.42 |
| Correlation with SPY (1Y) | -0.07 |
| 50-Day Average | $19.60 |
| 200-Day Average | $19.68 |
| 52-Week Range | $16.79 to $22.10 |
| RSI (14 Days) | 54.3 |
| Average Volume (20 Days) | 2.67M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Total debt is 0.86x shareholder equity.
| Debt / Equity | 0.86x |
|---|---|
| Debt / EBITDA | 8.71x |
| Debt / FCF | 7.12x |
| Interest Coverage | 11.69x |
Returns and Efficiency
Return on invested capital is 0.82% over the last 12 months, against a 5-year average of 1.09%.
| Return on Equity (ROE) | 2.51% |
|---|---|
| Return on Assets (ROA) | 1.31% |
| Return on Invested Capital (ROIC) | 0.82% |
| ROE (5Y Average) | 0.95% |
| ROA (5Y Average) | 0.45% |
| ROIC (5Y Average) | 1.09% |
| Asset Turnover | 0.17x |
Taxes
Income tax took 2.72% of pretax income over the last 12 months.
| Income Tax (TTM) | $1.77M |
|---|---|
| Effective Tax Rate | 2.72% |
Scores
SBRA has a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 6 of 9 |
|---|---|
| Piotroski Strength | Average |
Income Statement
FFO per share was $1.54 for 2025, the latest reported year. Revenue of $912.36M over the last 12 months is up 19.51% from the 12 months before.
| FFO Per Share (2025) | $1.54 |
|---|---|
| Revenue | $912.36M |
| Revenue Growth (YoY) | +19.51% |
| Pretax Income | $65.02M |
| Net Income | $71.27M |
| EBITDA | $279.59M |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 52.30% of the $5.43B in total assets.
| Cash and Equivalents | $36.24M |
|---|---|
| Total Debt | $2.44B |
| Net Debt | $2.40B |
| Net Debt Per Share | $9.39 |
| Shareholder Equity | $2.84B |
| Book Value Per Share | $11.11 |
| Tangible Book Value | $2.75B |
| Tangible Book Per Share | $10.77 |
| Total Assets | $5.43B |
| Total Liabilities | $2.59B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $58.40M of capital spending, operating cash flow left $342.18M of free cash flow.
| Operating Cash Flow | $400.58M |
|---|---|
| Capital Expenditures | $58.40M |
| Free Cash Flow | $342.18M |
| FCF Per Share | $1.34 |
| Depreciation and Amortization | $235.17M |
| Dividends Paid | $302.76M |
Trailing 12 months through Sep 30, 2026.
Margins
| Pretax Margin | 7.13% |
|---|---|
| Net Margin | 7.81% |
| EBITDA Margin | 30.65% |
| FCF Margin | 37.51% |
| Gross Margin (5Y Average) | 77.69% |
| Operating Margin (5Y Average) | 39.54% |
| Net Margin (5Y Average) | -0.22% |
Growth
FFO per share fell 0.64% a year over 3 years, and revenue grew 15.00% a year.
| FFO Per Share Growth (3Y CAGR) | -0.64% |
|---|---|
| Revenue Growth (3Y CAGR) | +15.00% |
| Revenue Growth (5Y CAGR) | +6.07% |
| FCF Growth (3Y CAGR) | +5.54% |
| FCF Growth (5Y CAGR) | -0.03% |
| Operating Income Growth (3Y CAGR) | +3.96% |
| Book Value Per Share Growth (2Y CAGR) | -3.62% |
| Tangible Book Per Share Growth (2Y CAGR) | -4.21% |
Dividends and Yields
SBRA pays out 77.92% of 2025 FFO as dividends.
| Dividend Per Share (Annual) | $1.20 |
|---|---|
| Dividend Yield | 5.93% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | 0.00% |
| Dividend Growth (5Y CAGR) | -2.33% |
| Payout Ratio (2025 FFO) | 77.92% |
| FCF Payout Ratio | 88.48% |
| FFO Yield (2025) | 7.60% |
| FCF Yield | 6.61% |
| Buyback Yield | -3.92% |
| Shareholder Yield | 1.93% |
Stock Splits
The last split was a 1-for-3 reverse split on Nov 16, 2010.
| Last Split Date | Nov 16, 2010 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:3 |
Peer Position
Against 12 similar companies, SBRA has the 6th highest P/FFO and the 7th highest P/S.
P/FFOPeer median 11.7x
P/S RatioPeer median 5.5x
ROICPeer median 3.37%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +10.13%
Dividend YieldPeer median 5.31%
| P/FFO | 12.1x vs 11.7x median |
|---|---|
| P/S Ratio | 5.7x vs 5.5x median |
| ROIC | 0.82% vs 3.37% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +19.51% vs +10.13% median |
| Dividend Yield | 5.93% vs 5.31% median |
Analyst Forecast
FFO per share estimates imply 5.38% growth a year over the next 2 years. Consensus estimates put revenue growth at 12.57% a year over the next 2 fiscal years.
| FFO Per Share Growth Forecast (2Y CAGR) | +5.38% |
|---|---|
| Revenue Growth Forecast (2Y CAGR) | +12.57% |
| EPS Growth Forecast (2Y CAGR) | -14.19% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About SBRA
What is SBRA's market cap?
Sabra Healthcare REIT has a market cap of $5.33B. Its enterprise value, which adds debt and subtracts cash, is $7.73B.
What is SBRA's price to FFO ratio?
Sabra Healthcare REIT has a P/FFO of 12.1x on its 2026 FFO estimate.
How many shares of SBRA are outstanding?
Sabra Healthcare REIT has 255.60M shares outstanding. The count is up 6.55% from a year earlier.
Does SBRA pay a dividend?
Yes. Sabra Healthcare REIT pays $1.20 a share a year, a dividend yield of 5.93%.
How much debt does SBRA have?
Sabra Healthcare REIT has $2.44B of total debt and $36.24M of cash and equivalents, a net debt position of $2.40B.
SBRA pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors